Cardinal Health Files 8-K on Agreements and Obligations
Ticker: CAH · Form: 8-K · Filed: Nov 22, 2024 · CIK: 721371
| Field | Detail |
|---|---|
| Company | Cardinal Health INC (CAH) |
| Form Type | 8-K |
| Filed Date | Nov 22, 2024 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $500,000,000, $750,000,000, $1,000,000,000, $650,000,000, $2.9 b |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-obligation, corporate-action
TL;DR
Cardinal Health 8-K: Material agreements entered and terminated, new financial obligations created. Watch for impacts.
AI Summary
On November 22, 2024, Cardinal Health, Inc. filed an 8-K report detailing the entry into and termination of material definitive agreements, as well as the creation of direct financial obligations. The filing indicates significant corporate actions related to financial commitments and agreements.
Why It Matters
This filing signals potential shifts in Cardinal Health's financial structure and contractual relationships, which could impact its operational and financial performance.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and financial obligations, which inherently carry financial and operational risks.
Key Players & Entities
- Cardinal Health, Inc. (company) — Registrant
- November 22, 2024 (date) — Date of earliest event reported
- Ohio (location) — State of incorporation
- 7000 Cardinal Place, Dublin, Ohio 43017 (address) — Principal Executive Offices
FAQ
What specific material definitive agreements were entered into by Cardinal Health, Inc. on or before November 22, 2024?
The filing indicates the entry into material definitive agreements, but the specific details of these agreements are not provided in the summary information.
Which material definitive agreements has Cardinal Health, Inc. terminated as reported in this 8-K?
The filing states the termination of material definitive agreements, but the specific agreements terminated are not detailed in the provided text.
What are the nature of the direct financial obligations or off-balance sheet arrangements created by Cardinal Health, Inc.?
The 8-K reports the creation of direct financial obligations or obligations under off-balance sheet arrangements, but the specifics are not elaborated in the summary.
What is the significance of the 'Financial Statements and Exhibits' item listed in the filing?
This item indicates that financial statements and exhibits are being filed as part of this report, which would contain more detailed financial information and supporting documents.
When was Cardinal Health, Inc. incorporated, and in which state?
Cardinal Health, Inc. was incorporated in Ohio, as stated in the filing.
Filing Stats: 1,400 words · 6 min read · ~5 pages · Grade level 9.4 · Accepted 2024-11-22 16:46:52
Key Financial Figures
- $500,000,000 — ompany") completed a public offering of $500,000,000 aggregate principal amount of 4.700% No
- $750,000,000 — 700% Notes due 2026 (the "2026 Notes"), $750,000,000 aggregate principal amount of 5.000% No
- $1,000,000,000 — 000% Notes due 2029 (the "2029 Notes"), $1,000,000,000 aggregate principal amount of 5.350% No
- $650,000,000 — % Notes due 2034 (the "2034 Notes") and $650,000,000 aggregate principal amount of 5.750% No
- $2.9 b — ity in an aggregate principal amount of $2.9 billion, the proceeds of which may be use
Filing Documents
- d877130d8k.htm (8-K) — 35KB
- d877130dex42.htm (EX-4.2) — 408KB
- d877130dex51.htm (EX-5.1) — 10KB
- d877130dex52.htm (EX-5.2) — 25KB
- 0001193125-24-264393.txt ( ) — 692KB
- cah-20241122.xsd (EX-101.SCH) — 2KB
- cah-20241122_lab.xml (EX-101.LAB) — 17KB
- cah-20241122_pre.xml (EX-101.PRE) — 11KB
- d877130d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d)Exhibits Exhibit No. Description 4.1 Indenture, dated as of June 2, 2008, between Cardinal Health, Inc., as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 to Cardinal Health, Inc.'s Current Report on Form 8-K filed on June 2, 2008). 4.2 Second Supplemental Indenture, dated as of November 22, 2024, between Cardinal Health, Inc., as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee. 4.3 Form of 4.700% Senior Notes due 2026 (included in Exhibit 4.2). 4.4 Form of 5.000% Senior Notes due 2029 (included in Exhibit 4.2). 4.5 Form of 5.350% Senior Notes due 2034 (included in Exhibit 4.2). 4.6 Form of 5.750% Senior Notes due 2054 (included in Exhibit 4.2). 5.1 Opinion of Patrick Pope, Executive Vice President, General Counsel and Secretary of Cardinal Health, Inc. 5.2 Opinion of Skadden, Arps, Slate, Meagher & Flom LLP. 23.1 Consent of Patrick Pope, Executive Vice President, General Counsel and Secretary (included in Exhibit 5.1). 23.2 Consent of Skadden, Arps, Slate, Meagher & Flom LLP (included in Exhibit 5.2). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
Signatures
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cardinal Health, Inc. (Registrant) Date: November 22, 2024 By: /s/ AARON E. ALT Aaron E. Alt Chief Financial Officer